Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
SNTS > SEC Filings for SNTS > Form 8-K on 12-Nov-2013All Recent SEC Filings

Show all filings for SANTARUS INC

Form 8-K for SANTARUS INC


12-Nov-2013

Other Events


Item 8.01. Other Events.

On November 8, 2013, Depomed, Inc. ("Depomed"), Valeant International Bermuda ("Valeant"), and Santarus, Inc. ("Santarus") on the one hand, and each of Watson Laboratories, Inc.-Florida, Actavis, Inc., and Actavis Pharma, Inc. (collectively, "Watson") entered into a settlement and license agreement (the "Settlement Agreement") to resolve pending patent litigation involving GlumetzaŽ (extended release metformin tablets) 500 mg and 1000 mg.

The Settlement Agreement grants Watson the right to begin selling a generic version of Glumetza on August 1, 2016, or earlier under certain circumstances. The Settlement Agreement is subject to review by the U.S. Department of Justice and the Federal Trade Commission, as well as entry by the U.S. District Court for the District of Delaware of an order dismissing the litigation.


  Add SNTS to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for SNTS - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.